U.S Class(es): 005, 006, 018, 044, 046, 051, 052
Class Status: Active
| Name | Laurence Rickles TEVA PHARMACEUTICALS USA, INC. |
|---|---|
| Address | 400 INTERPACE PARKWAY BUILDING A PARSIPPANY, NJ 07054 United States |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Nov-09-2021 | NEW APPLICATION ENTERED | NWAPI | |
| Nov-15-2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
| May-25-2022 | ASSIGNED TO EXAMINER | DOCKD | |
| May-25-2022 | SUSPENSION LETTER WRITTEN | CNSLR | |
| May-25-2022 | LETTER OF SUSPENSION E-MAILED | GNSLF | |
| May-25-2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | GNS3O | |
| Dec-06-2022 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | ERSII | |
| Jan-30-2023 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | RCCKS | |
| Jan-30-2023 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAP | |
| Feb-15-2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
| Mar-07-2023 | PUBLISHED FOR OPPOSITION | PUBOA | |
| Mar-07-2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
| Apr-06-2023 | EXTENSION OF TIME TO OPPOSE RECEIVED | ETOFT | |
| Apr-21-2023 | TEAS POST PUBLICATION AMENDMENT RECEIVED | EPPAI | |
| May-11-2023 | ASSIGNED TO PETITION STAFF | APETA | |
| May-11-2023 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | CHPBI | |
| May-17-2023 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | ETOPT | |
| Jun-27-2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | NOAME | |
| Dec-20-2023 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
| Dec-20-2023 | SOU EXTENSION 1 FILED | EXT1S | |
| Dec-20-2023 | SOU EXTENSION 1 GRANTED | EX1GS | |
| Dec-22-2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
| Jun-10-2024 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
| Jun-10-2024 | SOU EXTENSION 2 FILED | EXT2S | |
| Jun-10-2024 | SOU EXTENSION 2 GRANTED | EX2GS | |
| Jun-13-2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE |